Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer()

OBJECTIVE: Our goal was to evaluate the effects of simvastatin on endometrial cancer cell lines and primary cultures of endometrial cancer cells. METHODS: Cell proliferation in the ECC-1 and Ishikawa endometrial cancer cell lines and primary cultures of endometrial cancer cells was assessed by MTT a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schointuch, Monica N., Gilliam, Timothy P., Stine, Jessica E., Han, Xiaoyun, Zhou, Chunxiao, Gehrig, Paola A., Kim, Kenneth, Bae-Jump, Victoria L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125536/
https://ncbi.nlm.nih.gov/pubmed/24880141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2014.05.015
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge